Logo Precision Medicine in Chronic Inflammation

International Symposium PMI 2020

Inflammation Medicine - From Bench to Bedside

February 17/18, 2020 in Hamburg

The new PMI website is still being developed, so we are getting started with a provisional one.


Intestinal inflammation: immune cells protect nerve cells after infection (pdf)
International research team involving the Cluster of Excellence PMI publishes new findings on the functions of the gut-brain axis
Rapid emergence of antibiotic resistance during standard therapy
Kiel research team investigates how the pathogen Pseudomonas aeruginosa becomes resistant to antibiotics during treatment of cystic fibrosis patients
Intestinal bacteria could influence the development of multiple sclerosis (pdf)
A tryptophan-free diet in mice changes the composition of the intestinal bacteria and protects against symptoms of experimentally generated multiple sclerosis
19.10.2019, unizeit
Inflammation medicine – the Kiel model
The Comprehensive Center for Inflammation Medicine (CCIM) is still unique in Germany even ten years after it was inaugurated. The special outpatient clinic for chronic inflammatory diseases shows how interdisciplinary cooperation works for both the clinic and research.
The best of both worlds: a designer molecule to combat type 2 diabetes (pdf)
A team of scientists from Kiel and Melbourne have developed a new protein from two naturally occurring proteins, which has proven very effective against type 2 diabetes in laboratory experiments.
New insights into how diet and medication impact the influence of gut bacteria on our health
Research published in Cell on 29th August by the groups of Filipe Cabreiro from the MRC London Institute of Medical Sciences and Imperial College and Christoph Kaleta from Kiel University in Germany has demonstrated that diet can alter the effectiveness of a type-2 diabetes drug via its action on gut bacteria.
Intestinal bacteria in type 2 diabetes: being overweight is pivotal (pdf)
A Kiel-based research team has been able to show that changes in the composition of intestinal bacteria in those with type 2 diabetes is linked more to being overweight and taking supplements or medication, and less to diabetes itself.
Plan B for Cholesterol Transport
Prof. Paul Saftig and his team prove the existence of a previously unknown alternative cholesterol transport mechanism inside cells
Inflammatory Bowel Disease: Assessment of metabolism of intestinal bacteria helps predict treatment success
Members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) have developed a new approach for personalized medicine in patients with inflammatory bowel diseases.
Cluster member Michael Stolpe of the Kiel Institute for the World Economy will give invited presentation on "Using Evidence-based Medicine to Raise the Productivity of Healthcare in Aging Populations" at the T20 Summit on 26-27 May 2019 in Tokyo, a high-level conference of the research and policy advice network for the G20 countries “Think20”. The summit is hosted by the government of Japan and the Asian Development Bank Institute (ADBI) in preparation of the G20 Summit of world leaders at the end of June 2019 in Osaka. For more information, go to https://t20japan.org. Download Michael Stolpe's Policy Brief "Use Evidence-based Medicine to Raise the Productivity of Healthcare in Aging Populations" at https://t20japan.org/policy-brief-productivity-healthcare-aging-populations/